In Cough with mucus Cafe Cof Plus Syrup gives relief from cough with mucus. It helps to loosen thick mucus, making it easier to cough out. This makes breathing easy and reduces the frequency of coughing. Cafe Cof Plus Syrup also relieves allergy symptoms like itchy or watery eyes, sneezing and runny nose. Apart from this, it produces a sensation of coolness and relieves minor throat irritation. Cafe Cof Plus Syrup usually starts to work within a few minutes and the effects can last up to several hours. Along with medications, drink enough luke warm water and gargle with warm salt water to ease the symptoms.
Cafe Cof Plus Syrup may cause excessive drowsiness with alcohol.
Cafe Cof Plus Syrup may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Cafe Cof Plus Syrup during breastfeeding is not available. Please consult your doctor.
It is not known whether Cafe Cof Plus Syrup alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Cafe Cof Plus Syrup is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Cafe Cof Plus Syrup may not be needed in these patients. Please consult your doctor.
Cafe Cof Plus Syrup is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Cafe Cof Plus Syrup may not be needed in these patients. Please consult your doctor.
If you miss a dose of Cafe Cof Plus Syrup, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Aaztrazivixa Lifesciences || ₹14.5/tablet (25% cheaper)